Cite
MLA Citation
Arlene Chan et al.. “Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply.” Lancet oncology, vol. 17, no. 5, n.d., pp. e176–e177. http://access.bl.uk/ark:/81055/vdc_100032015752.0x000041
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Arlene Chan et al.. “Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's reply.” Lancet oncology, vol. 17, no. 5, n.d., pp. e176–e177. http://access.bl.uk/ark:/81055/vdc_100032015752.0x000041